Latest news
Lilly beats estimates on resilient demand for injectable GLP-1 drugs, widens gap with Novo - 93.3 The Drive93.3 The Drive · Thu, 06 Aug 2026 04:36:48 GMTEli Lilly’s Obesity Drugs Drive Massive Revenue Growth - ForbesForbes · Wed, 05 Aug 2026 21:00:36 GMTEli Lilly to offer early access to next-gen obesity drug to some patients - 93.3 The Drive93.3 The Drive · Mon, 03 Aug 2026 22:51:27 GMT